PlexBio Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	153.06	128.06	167.18	191.19	124.94	101.35
Revenue Growth (YoY)	47.69%	-23.40%	-12.56%	53.02%	23.28%	42.38%
Cost of Revenue	103.88	78.8	104.71	132.19	86.38	59.67
Gross Profit	49.18	49.26	62.47	59	38.56	41.68
Selling, General & Admin	53.84	59.5	63.65	53.32	60.51	76.62
Research & Development	57.68	69.29	62.97	72.61	113.31	113.37
Operating Expenses	111.52	128.79	126.62	125.93	173.82	189.99
Operating Income	-62.35	-79.53	-64.15	-66.94	-135.26	-148.31
Interest Expense	-0.21	-0.16	-0.26	-0.17	-0.23	-0.23
Interest & Investment Income	9.63	9.58	8.27	3.01	2.31	4.21
Currency Exchange Gain (Loss)	-11.87	7.84	-2.88	10.06	-2.01	-4.94
Other Non Operating Income (Expenses)	0.28	0.63	0.49	0.9	4.08	13.53
EBT Excluding Unusual Items	-64.51	-61.63	-58.53	-53.14	-131.11	-135.74
Gain (Loss) on Sale of Assets	-	-	-	-	-0.48	-5.33
Pretax Income	-64.51	-61.63	-58.53	-53.14	-131.59	-141.07
Net Income	-64.51	-61.63	-58.53	-53.14	-131.59	-141.07
Net Income to Common	-64.51	-61.63	-58.53	-53.14	-131.59	-141.07
Shares Outstanding (Basic)	104	104	104	104	104	103
Shares Outstanding (Diluted)	104	104	104	104	104	103
Shares Change (YoY)	-	-	-	0.11%	0.51%	28.99%
EPS (Basic)	-0.62	-0.59	-0.56	-0.51	-1.27	-1.37
EPS (Diluted)	-0.62	-0.59	-0.56	-0.51	-1.27	-1.37
Free Cash Flow	-163.1	-8.64	-32.11	-73.02	-95.94	-116.71
Free Cash Flow Per Share	-1.57	-0.08	-0.31	-0.70	-0.93	-1.13
Gross Margin	32.13%	38.46%	37.37%	30.86%	30.86%	41.13%
Operating Margin	-40.73%	-62.10%	-38.38%	-35.01%	-108.26%	-146.34%
Profit Margin	-42.15%	-48.13%	-35.01%	-27.79%	-105.32%	-139.19%
Free Cash Flow Margin	-106.56%	-6.75%	-19.21%	-38.19%	-76.78%	-115.16%
EBITDA	-53.35	-69.67	-55.06	-55.76	-121.46	-132.73
EBITDA Margin	-34.85%	-54.40%	-32.93%	-29.17%	-97.21%	-130.97%
D&A For EBITDA	9	9.86	9.09	11.17	13.8	15.58
EBIT	-62.35	-79.53	-64.15	-66.94	-135.26	-148.31
EBIT Margin	-40.73%	-62.10%	-38.37%	-35.01%	-108.26%	-146.34%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.